Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab

20260 citationsJournal Article

Authors

Yosuke Sugiyama · Nagoya City University Hospital

TAKU NAIKI · Nagoya City University

TOSHIHARU MORIKAWA · Nagoya City University

KUNIHIRO ODAGIRI · Nagoya City University Hospital

Yoshihisa Mimura · Nagoya City University Hospital

Yoshihiko Tasaki · Nagoya City University Hospital

Nobuhiko Shimizu

Abstract

A high GNRI level during PEM therapy is an important prognostic indicator in patients with mUC. A sustained GNRI is a predictive biomarker for PFS and OS.

Topics & Keywords

Inflammatory Biomarkers in Disease Prognosis Bladder and Urothelial Cancer Treatments Ferroptosis and cancer prognosis

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: Anticancer Research

Volume 46, Issue 4, pp. 2187-2198

DOI: 10.21873/anticanres.18107

Field-Weighted Citation Impact: 0.00